From Reuters.

President Trump’s import-levies bonanza (https://www.reuters.com/breakingviews/markets-tariff-carnage-can-get-much-much-worse-2025-04-07/) , however it evolves, is arbitrary enough to upend easy assumptions (https://www.reuters.com/breakingviews/big-pharma-has-partial-immunity-trump-tariffs-2025-04-09/) about how the White House (https://www.reuters.com/breakingviews/trumps-tariff-retreat-leaves-lasting-us-scars-2025-04-09/) , the Federal Reserve and American trade partners can or will proceed. In this week’s Viewsroom podcast, Breakingviews columnists gauge the fallout.

Visit the Thomson Reuters Privacy Statement (https://www.thomsonreuters.com/en/privacy-statement.html) for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices (https://megaphone.spotify.com/about-advertisements) to opt-out of targeted advertising.